Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN

BlackRock, Inc. reported a 5.40% stake in Eledon Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Jul 17, 2025

BlackRock, Inc. reported a 5.40% stake in Eledon Pharmaceuticals, Inc., 3,252,910 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).

Stake
5.40%
Shares
3,252,910
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.40%3,252,910

Source

View original at SEC

Related